GlassScriptPhysician profile
Mark Douglas Jenkins
NPI 1831132430
$3,364.22
in general payments reported to CMS, 2019-2025
13 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2021: $96.32 · 2022: $58.63 · 2023: $2,441 · 2024: $365 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,046 · Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,045.53 |
| Food and Beverage | $871.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,519.34 | 2022-2024 | Ankle Fracture System, Distal Femur Plate System, Clavicular Fracture Fixation |
| Bioventus LLC | $188.21 | 2019 | |
| Depuy Synthes Sales INC. | $138.35 | 2019-2021 | |
| Avita Medical Americas, LLC | $124.97 | 2023 | Recell |
| Stryker Corporation | $104.72 | 2019-2024 | Evolve Triad |
| Zimmer Biomet Holdings, INC. | $80.69 | 2024 | Advantagerib |
| Si-Bone, INC. | $58.36 | 2021-2025 | |
| Smith+Nephew, INC. | $49.94 | 2024-2025 | Stravix, Pico 7 |
| Orthofix Medical, INC. | $35.08 | 2024-2025 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $29.09 | 2025 | |
| Integra Lifesciences Corporation | $15.20 | 2019 | |
| Organogenesis INC. | $14.61 | 2022 | |
| Biocomposites INC | $5.66 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.